Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by sashapireltalaon Jan 11, 2021 10:40am

142 Views

Post# 32266611

The Lucrative Psychedelics Market

Sponsored Post

Go have some few minutes to check this out now, this might help you!

These other companies announced its foray into the growing psychedelics market on December 12 with its KetaDASH platform– an Intravenous based, home delivery service for patients who have been prescribed KT. The psychedelic drugs market might grow to approx $6.85 billion by 2027 at a CAGR of approx 16.3%

To make this venture happen, these other companies acquired the tangible and intangible assets of IV therapy company CureDash. CureDash currently operates an IV delivery platform that could seemingly become the backbone of KetaDASH. Check disclaimer on my profile and landing page.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario